Where Technology meets Opportunity in Science and Engineering
Power At your Finger Tips
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech :- Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine :- Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech :- Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business :- Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News

    Total record(s) 1408 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>

    NIH Awards More than $48M to eMERGE Project to Correlate Genomic Data With ... - GenomeWeb

      They will also expand on the PREDICT program, a pharmacogenomics pipeline. The group will receive $3,353,476. Researchers at Cincinnati Children's Hospital Medical Center, led by John Harley, will sequence 10 ....more | Save |  Share  Email 1st Sep 2015 

    Video Shows Inmate Dying of Diabetes Complications in Rikers as Guards Did Nothing - Slate Magazine (blog)

      Slate Magazine (blog) A shocking new video released by the New York Times on Tuesday showed the final moments of the life of Carlos Mercado, a man who died of diabetes-related complications in poli ....more | Save |  Share  Email 1st Sep 2015 

    AMAG Pharmaceuticals to Present at Upcoming Investor Conferences - GlobeNewswire (press release)

      WALTHAM, Mass., Sept. 1, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG's business and financial outlook, strategy and growth ....more | Save |  Share  Email 1st Sep 2015 

    Rheumatologists Plan To Increase Their Use Of Pfizer's Xeljanz, Janssen's ... - MarketWatch

      ZUG, Switzerland, Sept. 1, 2015 /PRNewswire/ -- Feedback gathered from 101 rheumatologists in August reveals that while anti-TNF inhibitors remain entrenched in most practices, use of Xeljanz, Actemra an ....more | Save |  Share  Email 1st Sep 2015 

    Global Retinal Vein Occlusion Therapeutics Market: Industry Share, Trends ... - Medgadget.com (blog)

      Several treatment options have been identified including usage of corticosteroids such as intravitreal triamcinolone acetonide, dexamethasone and Anti-VEGF therapy. The application of vascula ....more | Save |  Share  Email 1st Sep 2015 

    Analysts' Weekly Ratings Updates for Bellicum Pharmaceuticals (BLCM) - Dakota Financial News

      8/26/2015 - Bellicum Pharmaceuticals was upgraded by analysts at Zacks from a "sell? rating to a "hold? rating. According to Zacks, "Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical ....more | Save |  Share  Email 1st Sep 2015 

    Amgen finds data falsified in obesity-diabetes study featuring grizzly bears - MarketWatch

      MarketWatch The paper discussed how grizzly bears' metabolisms adjust to hibernation, and the key role of a certain fat protein, which offered a clue to a new kind of treatment for diabetes. Biotech Amgen Inc. ....more | Save |  Share  Email 1st Sep 2015 

    Stock in Focus - China Biologic Products, Inc. (NASDAQ:CBPO) - Vanguard Tribune

      There are a number of sell-side research firms which cover China Biologic Products, Inc. (NASDAQ:CBPO) and offer projections on earnings and future stock movement. On a consensus basis, analysts have a one year target price ....more | Save |  Share  Email 1st Sep 2015 

    Amgen Finds Data Falsified in Obesity-Diabetes Study Featuring Grizzly Bears - Wall Street Journal

      Wall Street Journal A scientific paper that had captured widespread attention because its subjects were massive grizzly bears was retracted on Tuesday after one of the authors was said to have manipulated ....more | Save |  Share  Email 1st Sep 2015 

    AAA7 schedules diabetes program - Portsmouth Daily Times

      According to the 2014 National Diabetes Statistics Report, released by the Centers for Disease Control and Prevention, 29 million people in the U.S., ages 20 or older, have diabetes. That's 12.3 percent of the adult population and 1 in 4 do n ....more | Save |  Share  Email 1st Sep 2015 

    Chardan Capital Turns Bearish On Regeneron Pharmaceuticals Inc And Esperion ... - Bidness ETC

      Bidness ETC The first of PCSK9 inhibiting drug, Praluent, developed jointly by Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY), won the US Food and Drug Administration (FDA) approval ....more | Save |  Share  Email 1st Sep 2015 

    Coffee may increase risk for heart events, diabetes in young adults - UPI.com

      UPI.com The research, presented at the 2015 congress of the European Society of Cardiology, included data on 1,201 non-diabetic people between the ages of 18 and 45 with untreated stage 1 hypertension who participated in the 1 ....more | Save |  Share  Email 1st Sep 2015 

    ANI Pharmaceuticals (ANIP) Showing Signs Of A Dead Cat Bounce Today - TheStreet.com

      Trade-Ideas LLC identified ANI Pharmaceuticals ( ANIP) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified ANI Pharmaceut ....more | Save |  Share  Email 1st Sep 2015 

    Bayer Separates Material Science Business Covestro - Wall Street Journal

      Wall Street Journal That "growth potential? makes the business "very attractive from a shareholder's perspective,? he added. But for Bayer, which has in recent years has focused on its core Health Care business and its lucr ....more | Save |  Share  Email 1st Sep 2015 

    RXi Pharmaceuticals Corp Represents An Underappreciated Innovator With Upside ... - Smarter Analyst

      Smarter Analyst Although VEGF inhibitors including Regeneron's Eylea and Roche's Lucentis have significantly improved vision in many patients with the disease, those with advanced AMD face diminis ....more | Save |  Share  Email 1st Sep 2015 

    Public Release: 1-Sep-2015 New treatment strategy identified for tumors ... - EurekAlert (press release)

      If you have diabetes and cancer, here's some hope. In a new research report appearing in the September 2015 issue of The FASEB Journal, scientists reveal a newly discovered tissue- and organ-spe ....more | Save |  Share  Email 1st Sep 2015 

    Alexion Pharmaceuticals gets nods to market two medicines in Europe - Waterbury Republican American

      Waterbury Republican American 23 May 2011 - 052311DK01 -- A sign marks the entrance to Alexion Pharmaceutical's headquarters on Knotter Drive in Cheshire. The European Commission has given marketing a ....more | Save |  Share  Email 1st Sep 2015 

    World's first public biotech lab opens in La Jolla - 10News

      10News FILE -- A reagent is added to plates containing genes extracted from customers' saliva in preparation for genetic analysis for DeNA Life Science Inc.'s direct-to-consumer (DTC) genetic testing service "Mycode" durin ....more | Save |  Share  Email 1st Sep 2015 

    At Summer's End, Can Crossover Winds Stay At Biotech's Back? - Xconomy

      Xconomy For certain parts of the population, "summer? is a verb, and in the U.S., one does it until Labor Day. One more week, then, before sunburned financial types return to their desks and biotech IPO hopefuls hit the roa ....more | Save |  Share  Email 1st Sep 2015 

    Intercept Pharmaceuticals Inc (NASDAQ:ICPT) FDA Accepted Review for ... - Street Report

      Intercept Pharmaceuticals Inc (NASDAQ:ICPT) (TREND ANALYSIS) announced the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application and granted Priority Review for obet ....more | Save |  Share  Email 1st Sep 2015 
    Total record(s) 1408 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>
    weSRCH Android App